Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: FASEB J. 2020 Jan 8;34(2):3359–3366. doi: 10.1096/fj.201902842R

FIGURE 2.

FIGURE 2

ADE levels of complement regulatory proteins in sTBI and mtTBI subject groups. Each point represents the value for a control or TBI participant and the horizontal line in point clusters is the mean level for that group. Mean ± SEM for sTBI control, sTBI acute, sTBI chronic, mtTBI control, mtTBI early chronic, and mtTBI late chronic participant values, respectively, are 741 ± 79.6, 501 ± 21.6, 887 ± 74.0, 841 ± 54.9, 483 ± 90.6, and 586 ± 45.9 pg/mL for CR1 (A), 1196 ± 157, 740 ± 84.5, 1289 ± 118, 1233 ± 147, 870 ± 76.0, and 1334 ± 97.0 pg/mL for CD59 (B), and 5566 ± 538, 5545 ± 388, 6492 ± 666, 7957 ± 633, 8509 ± 967, and 6640 ± 430 pg/mL for factor I (C). The significance of differences shown between values for controls and TBI subjects were calculated by an unpaired Student’s t test; +P < .05, *P < .01